Free Trial

Titan Medical (TMDIF) Competitors

Titan Medical logo
$0.39 +0.04 (+10.74%)
As of 07/23/2025

TMDIF vs. PDEX, RCEL, BSGM, KRMD, PTHL, LAKE, LUCD, INFU, OBIO, and LUNG

Should you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include Pro-Dex (PDEX), Avita Medical (RCEL), Biosig Technologies (BSGM), KORU Medical Systems (KRMD), Pheton (PTHL), Lakeland Industries (LAKE), Lucid Diagnostics (LUCD), InfuSystem (INFU), Orchestra BioMed (OBIO), and Pulmonx (LUNG). These companies are all part of the "medical equipment" industry.

Titan Medical vs. Its Competitors

Pro-Dex (NASDAQ:PDEX) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

In the previous week, Pro-Dex had 1 more articles in the media than Titan Medical. MarketBeat recorded 1 mentions for Pro-Dex and 0 mentions for Titan Medical. Pro-Dex's average media sentiment score of 1.87 beat Titan Medical's score of 0.00 indicating that Pro-Dex is being referred to more favorably in the media.

Company Overall Sentiment
Pro-Dex Very Positive
Titan Medical Neutral

Titan Medical has lower revenue, but higher earnings than Pro-Dex. Titan Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro-Dex$64.12M2.53$2.13M$2.8017.79
Titan Medical$17.63M2.52$6.95M$0.057.79

Pro-Dex currently has a consensus price target of $56.00, suggesting a potential upside of 12.40%. Given Pro-Dex's stronger consensus rating and higher possible upside, equities analysts plainly believe Pro-Dex is more favorable than Titan Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Titan Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Pro-Dex has a net margin of 14.61% compared to Titan Medical's net margin of 0.00%. Pro-Dex's return on equity of 29.08% beat Titan Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Pro-Dex14.61% 29.08% 16.19%
Titan Medical N/A -82.31%-51.47%

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Pro-Dex has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500.

Summary

Pro-Dex beats Titan Medical on 14 of the 16 factors compared between the two stocks.

Get Titan Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMDIF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMDIF vs. The Competition

MetricTitan MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$44.44M$66.20M$5.73B$9.47B
Dividend YieldN/AN/A4.60%3.99%
P/E Ratio-0.316.0527.9819.95
Price / Sales2.52142.51451.34100.89
Price / Cash0.0218.4136.5558.97
Price / Book0.377.348.645.90
Net Income$6.95M-$25.32M$3.24B$258.42M
7 Day Performance5.32%1.35%3.69%2.11%
1 Month Performance27.88%4.16%10.34%12.44%
1 Year PerformanceN/A53.27%34.32%19.55%

Titan Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMDIF
Titan Medical
N/A$0.39
+10.7%
N/A+979.5%$44.44M$17.63M-0.3150Gap Up
PDEX
Pro-Dex
2.6063 of 5 stars
$46.02
+1.9%
$56.00
+21.7%
+159.2%$150.07M$64.12M16.44140Positive News
RCEL
Avita Medical
0.9436 of 5 stars
$5.51
+3.0%
$16.50
+199.5%
-40.6%$144.65M$71.66M-2.50130Positive News
BSGM
Biosig Technologies
1.5917 of 5 stars
$5.19
+13.3%
$10.00
+92.7%
+906.6%$141.66M$26K0.0050
KRMD
KORU Medical Systems
2.1881 of 5 stars
$3.03
+2.9%
$4.50
+48.8%
+37.1%$139.81M$35.08M-27.5580Positive News
PTHL
Pheton
N/A$20.89
+1.4%
N/AN/A$137.20M$450K0.0011
LAKE
Lakeland Industries
4.7504 of 5 stars
$13.56
-0.2%
$26.00
+91.8%
-36.6%$129.50M$167.21M-4.522,100
LUCD
Lucid Diagnostics
2.8361 of 5 stars
$1.15
-2.1%
$3.55
+210.0%
+29.4%$123.88M$4.35M-0.8570Positive News
Gap Up
INFU
InfuSystem
3.3205 of 5 stars
$5.58
+1.8%
$13.00
+133.1%
N/A$117.80M$137.58M93.43410News Coverage
Analyst Forecast
Analyst Revision
OBIO
Orchestra BioMed
3.1454 of 5 stars
$2.95
+1.0%
$14.20
+381.4%
-59.8%$113.01M$2.64M-1.664News Coverage
Positive News
LUNG
Pulmonx
3.6302 of 5 stars
$2.65
-1.9%
$11.53
+334.9%
-60.0%$106.69M$83.79M-1.84250News Coverage
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:TMDIF) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners